Kayla Ponder to Retroviridae
This is a "connection" page, showing publications Kayla Ponder has written about Retroviridae.
Connection Strength
0.532
-
Therapeutic levels of functional human factor X in rats after retroviral-mediated hepatic gene therapy. Blood. 1997 Feb 15; 89(4):1254-9.
Score: 0.135
-
Portal branch occlusion safely facilitates in vivo retroviral vector transduction of rat liver. Hum Gene Ther. 1996 Nov 10; 7(17):2113-21.
Score: 0.133
-
Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo. Hum Gene Ther. 1996 Mar 20; 7(5):637-45.
Score: 0.127
-
Intramuscular injection of an adenoviral vector expressing hepatocyte growth factor facilitates hepatic transduction with a retroviral vector in mice. Hum Gene Ther. 1999 Apr 10; 10(6):911-22.
Score: 0.039
-
Therapeutic levels of human protein C in rats after retroviral vector-mediated hepatic gene therapy. J Clin Invest. 1998 Jun 15; 101(12):2831-41.
Score: 0.037
-
In vivo hepatocyte transduction with retrovirus during in-flow occlusion. J Surg Res. 1993 May; 54(5):418-25.
Score: 0.026
-
Gene therapy ameliorates cardiovascular disease in dogs with mucopolysaccharidosis VII. Circulation. 2004 Aug 17; 110(7):815-20.
Score: 0.014
-
Optimization of liver-directed retroviral gene delivery. Transplant Proc. 1994 Dec; 26(6):3379-80.
Score: 0.007
-
Liver-directed gene therapy: evaluation of liver specific promoter elements. J Surg Res. 1994 Jun; 56(6):510-7.
Score: 0.007
-
Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc Natl Acad Sci U S A. 1992 Jan 01; 89(1):89-93.
Score: 0.006